rs3176337

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000389.5(CDKN1A):​c.-6+2345A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.643 in 152,012 control chromosomes in the GnomAD database, including 32,523 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.64 ( 32523 hom., cov: 31)

Consequence

CDKN1A
NM_000389.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.121

Publications

6 publications found
Variant links:
Genes affected
CDKN1A (HGNC:1784): (cyclin dependent kinase inhibitor 1A) This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene. [provided by RefSeq, Sep 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.803 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000389.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDKN1A
NM_000389.5
MANE Select
c.-6+2345A>C
intron
N/ANP_000380.1
CDKN1A
NM_001291549.3
c.98-2954A>C
intron
N/ANP_001278478.1
CDKN1A
NM_001374509.1
c.98-2954A>C
intron
N/ANP_001361438.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDKN1A
ENST00000244741.10
TSL:1 MANE Select
c.-6+2345A>C
intron
N/AENSP00000244741.6
CDKN1A
ENST00000405375.5
TSL:1
c.-6+2204A>C
intron
N/AENSP00000384849.1
CDKN1A
ENST00000373711.4
TSL:5
c.-96-1497A>C
intron
N/AENSP00000362815.1

Frequencies

GnomAD3 genomes
AF:
0.643
AC:
97649
AN:
151892
Hom.:
32463
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.810
Gnomad AMI
AF:
0.460
Gnomad AMR
AF:
0.680
Gnomad ASJ
AF:
0.634
Gnomad EAS
AF:
0.755
Gnomad SAS
AF:
0.650
Gnomad FIN
AF:
0.525
Gnomad MID
AF:
0.668
Gnomad NFE
AF:
0.545
Gnomad OTH
AF:
0.665
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.643
AC:
97773
AN:
152012
Hom.:
32523
Cov.:
31
AF XY:
0.645
AC XY:
47900
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.810
AC:
33601
AN:
41468
American (AMR)
AF:
0.680
AC:
10393
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.634
AC:
2197
AN:
3468
East Asian (EAS)
AF:
0.755
AC:
3894
AN:
5158
South Asian (SAS)
AF:
0.649
AC:
3122
AN:
4814
European-Finnish (FIN)
AF:
0.525
AC:
5545
AN:
10568
Middle Eastern (MID)
AF:
0.673
AC:
198
AN:
294
European-Non Finnish (NFE)
AF:
0.544
AC:
36991
AN:
67938
Other (OTH)
AF:
0.670
AC:
1414
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1663
3326
4990
6653
8316
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
774
1548
2322
3096
3870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.586
Hom.:
15838
Bravo
AF:
0.664
Asia WGS
AF:
0.721
AC:
2501
AN:
3468

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
6.7
DANN
Benign
0.46
PhyloP100
0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3176337; hg19: chr6-36648920; API